IMPROVE-CKD Study: Impact of a phosphate binder on cardiovascular disease in Chronic Kidney Disease. [ 2013 - ]

Research Grant

Researchers: Prof Carmel Hawley (Principal investigator) ,  A/Pr Eugenia Pedagogos ,  A/Pr Nigel Toussaint ,  Dr Geoffrey Block ,  Prof Grahame Elder
View all 8 related researchers

Brief description Chronic kidney disease (CKD) is a significant health problem and is associated with an increased risk of cardiovascular (CV) disease. Vascular calcification and arterial stiffness (stiffening of the blood vessels and arteries) are very common in people with CKD, and are linked to increased death from CV events. This study aims to examine the ways in which treatment with a phosphate binder, Lanthanum Carbonate, may reduce vascular calcification and arterial stiffness to decrease CV events.

Funding Amount $1,596,698.00

Funding Scheme Project Grants

Notes Standard Project Grant